亚托皮炎和IgE介导的食物过敏:治疗和预防的共同生物点
H Mark Kenney1, Jennifer Battaglia2, Katherine Herman3
1Department of Medicine, University of Rochester Medical Center, Rochester, New York.
概括
亚托皮炎 (AD) 和IgE介导的食物过敏 (IgE-FA) 分享生物疗法的共同目标,为治疗这两种疾病和预防儿童的亚托皮性进展提供了潜力. 需要进一步的研究来澄清长期疗效和预防策略.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 过敏 过敏是一种过敏.
背景情况:
- 亚托皮炎 (AD) 和IgE介导的食物过敏 (IgE-FA) 是普遍存在的慢性炎症状况,特别是在儿童群体中.
- 共同的病理生理特征包括表皮屏障缺陷,免疫失调和微生物组变化.
研究的目的:
- 确定治疗阿尔茨海默病和IgE-FA. 的常见机制性标.
- 探索治疗策略,有可能实现双重疗效和预防亚托皮性疾病.
- 专注于儿科患者,尤其是12岁以下的儿童.
主要方法:
- 对PubMed和ClinicalTrials.gov (NCT) 注册的试验进行系统审查.
- 重点是过去十年的人类研究,与临床前数据集成.
- 对儿科受试者 (<18岁) 的临床试验进行过,重点关注幼儿期 (<12岁).
主要成果:
- 阿尔茨海默病和IgE-FA具有共同的关键特征:上皮屏障功能障碍,免疫异常和微生物失调症.
- 针对性的生物疗法,如dupilumab (抗IL-4Rα) 和omalizumab (抗IgE),在减少儿童两种疾病的症状方面显示出有希望.
- 为早期风险预测开发生物标志物为初级预防提供了潜力.
结论:
- 艾滋病和IgE-FA之间的共同点允许开发统一的生物治疗策略.
- 生物药物可能为治疗这两种疾病提供了一条途径,并可能预防阿托皮症的进展.
- 未来的研究需要标准化的儿科年龄分层和优化的治疗方案,以改善解释.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
270
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
270
Allergic Reactions
27.3K
Overview
27.3K
Allergic Drug Reactions
833
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
833
Antibody Structure
59.9K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.9K
Hypersensitivities
586
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
586
Cross-reactivity
31.0K
Overview
31.0K


